Small-Molecule-Directed Endogenous Regeneration of Visual Function in a Mammalian Retinal Degeneration Model

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Neuroscience

Background:

• Degenerative retinal diseases cause significant visual impairment globally.
• Current treatments for photoreceptor loss are limited.
• Endogenous retinal regeneration remains a therapeutic challenge.

Purpose of the Study:

• To develop a small molecule promoting retinal stem/progenitor cell proliferation.
• To evaluate the therapeutic potential of this molecule in a murine model of retinal degeneration.

Main Methods:

• Small molecule development using phenotypic profiling and medicinal chemistry.
• In vitro assessment using neurosphere assays.
• In vivo studies in a mouse model of N-methyl-N-nitrosourea (MNU)-induced retinal degeneration.
• Functional vision tests including electroretinography (ERG), visual acuity, and contrast sensitivity.

Main Results:

• The developed small molecule demonstrated proliferative effects on retinal stem/progenitor cells.
• Intravitreal injections in the MNU-induced retinal degeneration model improved outer nuclear layer thickness.
• Significant regeneration of visual function was observed, evidenced by improved ERG, visual acuity, and contrast sensitivity.

Conclusions:

• The study presents a proof-of-concept for using a small molecule to promote endogenous retinal regeneration.
• This approach holds promise for treating degenerative retinal diseases associated with photoreceptor loss.